• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Churchill Capital Corp X

    11/12/25 4:36:20 PM ET
    $CCCX
    Blank Checks
    Finance
    Get the next $CCCX alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    CHURCHILL CAPITAL CORP X-A

    (Name of Issuer)


    COMMON-STOCK

    (Title of Class of Securities)


    G2130T108

    (CUSIP Number)


    09/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    G2130T108


    1Names of Reporting Persons

    Barclays PLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED KINGDOM
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    3,017,851.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    3,017,851.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    3,017,851.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    8.63 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    CHURCHILL CAPITAL CORP X-A
    (b)Address of issuer's principal executive offices:

    640 Fifth Avenue, 14th Floor, NY, 10019
    Item 2. 
    (a)Name of person filing:

    Barclays PLC
    (b)Address or principal business office or, if none, residence:

    1 Churchill Place, London - E14 5HP
    (c)Citizenship:

    X0
    (d)Title of class of securities:

    COMMON-STOCK
    (e)CUSIP No.:

    G2130T108
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    3017851
    (b)Percent of class:

    8.63  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    3017851

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    3017851

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    Barclays Bank PLC, Barclays Capital Inc
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Barclays PLC
     
    Signature:Ramya Rao
    Name/Title:Director
    Date:11/12/2025
    Get the next $CCCX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CCCX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CCCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Murphy Stephen Anthony

    3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    8/11/25 4:43:36 PM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Lapping Paul

    3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)

    8/11/25 4:21:06 PM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Infleqtion Chief Scientist Dr. Mark Saffman Wins Prestigious 2026 Norman F. Ramsey Prize

    Award from American Physical Society honors Dr. Saffman's pioneering work in neutral-atom quantum technologies Infleqtion, a global leader in neutral atom–based quantum technology, proudly announces that Dr. Mark Saffman, Chief Scientist for Quantum Information at Infleqtion, has been awarded the prestigious Norman F. Ramsey Prize by the American Physical Society (APS). This recognition underscores the global scientific validation of the neutral-atom approach that powers Infleqtion's product roadmap, bridging world-class academic research with engineered quantum systems designed for scale, reliability, and real-world impact. Infleqtion recently announced plans to go public through a merge

    11/20/25 9:00:00 AM ET
    $CCCX
    Blank Checks
    Finance

    Infleqtion Appoints Jason Hall as Chief Legal Officer

    Hall's appointment strengthens Infleqtion's leadership team as the company advances toward its planned public listing and prepares for its next phase of strategic growth. Global legal executive with more than 15 years of leadership across technology, semiconductor, and energy sectors Former chief legal officer of Renesas Electronics Corporation, a multibillion-dollar publicly traded semiconductor company Led legal strategy on more than $15 billion in acquisitions, more than $6 billion in financings and company-wide strategic initiatives across five continents Infleqtion (the "Company"), a global leader in neutral atom-based quantum technology, has appointed Jason Hall as chief l

    11/19/25 4:15:00 PM ET
    $CCCX
    Blank Checks
    Finance

    Infleqtion and Oak Ridge National Laboratory Partner to Advance Quantum–HPC Integration

    $125M DOE Quantum Science Center renewal accelerates hybrid quantum/classical computing research Infleqtion, a global leader in neutral atom based quantum technology, is collaborating with Oak Ridge National Laboratory (ORNL) through the Department of Energy's Quantum Science Center (QSC) to explore how quantum computers can integrate with the world's most powerful high-performance computing (HPC) systems. The joint research aims to demonstrate real-world utility from hybrid computing systems and establish scalable pathways for future fault-tolerant, quantum accelerated supercomputers. This announcement follows Infleqtion's plans to go public through a merger with Churchill Capital Corp X

    11/18/25 9:00:00 AM ET
    $CCCX
    Blank Checks
    Finance

    $CCCX
    SEC Filings

    View All

    SEC Form 425 filed by Churchill Capital Corp X

    425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    11/19/25 4:15:31 PM ET
    $CCCX
    Blank Checks
    Finance

    SEC Form 425 filed by Churchill Capital Corp X

    425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    11/14/25 4:45:37 PM ET
    $CCCX
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Churchill Capital Corp X

    SCHEDULE 13G/A - Churchill Capital Corp X/Cayman (0002007825) (Subject)

    11/14/25 4:13:54 PM ET
    $CCCX
    Blank Checks
    Finance